Myelodysplasia, Neuroblastoma, Prolonged bleeding time, Thrombocytopenia

abnormal common myeloid progenitor cell morphology, abnormal definitive hematopoiesis, abnormal dorsal aorta morphology, abnormal double-positive T cell morphology, abnormal embryonic hematopoiesis, abnormal erythroid progenitor cell morphology, abnormal erythropoiesis, abnormal granulocyte differentiation, abnormal hematopoietic cell number, abnormal hematopoietic stem cell morphology, abnormal hematopoietic system morphology/development, abnormal immune system organ morphology, abnormal inguinal lymph node morphology, abnormal leukopoiesis, abnormal lymph node size, abnormal lymph organ development, abnormal megakaryocyte differentiation, abnormal megakaryocyte morphology, abnormal megakaryocyte progenitor cell morphology, abnormal myeloblast morphology/development, abnormal myelopoiesis, abnormal pericyte morphology, abnormal sensory neuron innervation pattern, abnormal skeleton development, abnormal spleen white pulp morphology, abnormal sternum morphology, abnormal sympathetic neuron physiology, abnormal thymus corticomedullary boundary morphology, abnormal thymus lobule morphology, abnormal thymus medulla morphology, abnormal vascular branching morphogenesis, abnormal vitelline vascular remodeling, abnormal xiphoid process morphology, abnormal zigzag hair morphology, arrested T cell differentiation, behavior/neurological phenotype, decreased CD4-positive, alpha beta T cell number, decreased Peyer's patch number, decreased body size, decreased curvature of zigzag hairs, decreased double-negative T cell number, decreased double-positive T cell number, decreased erythrocyte cell number, decreased hematocrit, decreased hematopoietic cell number, decreased hematopoietic stem cell number, decreased immature B cell number, decreased mature B cell number, decreased mean corpuscular volume, decreased pre-pro B cell number, decreased sensory neuron number, decreased single-positive T cell number, decreased spleen white pulp amount, decreased thymocyte number, decreased thymus weight, dilated vasculature, embryo phenotype, embryo tissue necrosis, embryonic lethality, embryonic lethality during organogenesis, complete penetrance, hematopoietic system phenotype, hypoalgesia, immune system phenotype, impaired hematopoiesis, impaired myelopoiesis, increased CD4-positive, alpha beta T cell number, increased CD8-positive, alpha-beta T cell number, increased T cell derived lymphoma incidence, increased curvature of auchene hairs, increased double-negative T cell number, increased double-positive T cell number, increased erythrocyte cell number, increased granulocyte number, increased hematopoietic stem cell number, increased incidence of tumors by chemical induction, increased lymphoma incidence, increased macrophage cell number, increased mature B cell number, increased metastatic potential, increased neutrophil cell number, increased nucleated erythrocyte cell number, increased number of Howell-Jolly bodies, increased pro-B cell number, increased red blood cell distribution width, increased sensitivity to induced morbidity/mortality, increased spleen red pulp amount, increased spleen weight, increased thymocyte apoptosis, increased tumor incidence, lethality throughout fetal growth and development, complete penetrance, lethality throughout fetal growth and development, incomplete penetrance, myeloid hyperplasia, no abnormal phenotype detected, pale liver, postnatal lethality, complete penetrance, postnatal lethality, incomplete penetrance, premature death, skeleton phenotype, skin edema, slow postnatal weight gain, small Peyer's patches, small spleen, small thymus, spinal hemorrhage, thymus cyst